1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with jte 013 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaneko, S; Okamoto, Y; Sugimoto, N; Takamura, M; Takashima, S; Takata, S; Takuwa, N; Takuwa, Y; Yoshioka, K | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and jte 013
Article | Year |
---|---|
G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; ADP Ribose Transferases; Animals; Botulinum Toxins; Calcium; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, G12-G13; GTP-Binding Protein alpha Subunits, Gq-G11; Lysophospholipids; Male; Muscle, Smooth, Vascular; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrazoles; Pyridines; rac GTP-Binding Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Lysosphingolipid; Recombinant Fusion Proteins; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Sphingosine; Transfection | 2008 |